| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,025 |
16,736 |
$2.92M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,023 |
14,019 |
$2.46M |
| X5622 |
|
894 |
782 |
$135K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
742 |
565 |
$55K |
| 99441 |
|
258 |
166 |
$16K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
223 |
180 |
$10K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
272 |
219 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
681 |
614 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
162 |
116 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
107 |
91 |
$6K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
175 |
131 |
$5K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
95 |
74 |
$5K |
| 99215 |
Prolong outpt/office vis |
29 |
26 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,088 |
1,723 |
$3K |
| 99243 |
|
42 |
26 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
9,236 |
6,821 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,220 |
2,517 |
$808.02 |
| 0072A |
|
16 |
16 |
$671.20 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,757 |
1,330 |
$615.38 |
| 0004A |
|
14 |
14 |
$545.35 |
| 90686 |
|
2,168 |
1,659 |
$507.17 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,078 |
860 |
$395.69 |
| 90461 |
|
617 |
450 |
$318.75 |
| 85027 |
|
1,059 |
814 |
$275.17 |
| 90662 |
|
12 |
12 |
$243.04 |
| 96127 |
|
1,001 |
732 |
$201.43 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,325 |
1,007 |
$172.40 |
| 87634 |
|
12 |
12 |
$147.22 |
| 80061 |
Lipid panel |
55 |
51 |
$141.35 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,244 |
1,048 |
$125.94 |
| 99442 |
|
219 |
143 |
$121.83 |
| 92551 |
|
1,189 |
934 |
$105.79 |
| 80053 |
Comprehensive metabolic panel |
71 |
54 |
$99.20 |
| 81001 |
|
135 |
124 |
$79.92 |
| 81003 |
|
801 |
486 |
$78.38 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
678 |
483 |
$74.99 |
| 90480 |
|
28 |
12 |
$60.48 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
14 |
14 |
$32.84 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
402 |
316 |
$26.88 |
| 99173 |
|
926 |
737 |
$23.66 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
312 |
240 |
$10.79 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25 |
24 |
$7.91 |
| 90670 |
|
181 |
109 |
$0.00 |
| 0002A |
|
258 |
258 |
$0.00 |
| 90633 |
|
35 |
27 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
250 |
226 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
28 |
24 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,117 |
1,084 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
329 |
208 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
112 |
52 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
467 |
294 |
$0.00 |
| 87210 |
|
66 |
54 |
$0.00 |
| 90685 |
|
72 |
62 |
$0.00 |
| 81002 |
|
53 |
30 |
$0.00 |
| 90656 |
|
17 |
12 |
$0.00 |
| 90651 |
|
86 |
66 |
$0.00 |
| 0001A |
|
255 |
255 |
$0.00 |
| 84703 |
|
30 |
26 |
$0.00 |
| 87081 |
|
84 |
84 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
67 |
65 |
$0.00 |
| 90647 |
|
12 |
12 |
$0.00 |
| 36416 |
|
23 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
22 |
12 |
$0.00 |
| 99443 |
|
12 |
12 |
$0.00 |